Medical Device News Magazine

Diabetes

Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin

This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.

DreaMed Launches its FDA-Cleared Diabetes Management Platform with a Leading U.S. Children’s Hospital

Advisor Pro is the first decision support system to receive FDA clearances for Type 1 and Type 2 diabetes treatments – for pediatrics and adults.

Tandem Diabetes Care Reports Health Canada Approval of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology

Tandem Diabetes Care notes all in-warranty t:slim X2 pump users in Canada will have the option to add Control-IQ technology to their existing pump beginning in March 2021 via remote software update.

In-Pen with Real-Time Connect CGM Data: 1st Integrated Smart Insulin Pen for People with Diabetes on Multiple Daily Injections

InPen is the first and only FDA-cleared smart insulin pen on the market for people on multiple daily insulin injections.
- Advertisement -spot_img

Latest News

Oblemic: A Comprehensive Review & Latest Research

Oblemic Reviews suggest that by integrating this supplement with healthy lifestyle choices, individuals may see significant improvements in their health. Unlike injectable treatments such as Ozempic and Wegovy, Oblemic is designed to provide similar benefits without the associated side effects.
- Advertisement -spot_img